Tag: Product liability lawyers

Wegovy and Ozempic Linked to Vision Loss

Posted on by Loni Liss

Novo Nordisk Failed to Warn Patients of the Risk of NAION and Permanent Blindness

After a thorough investigation into the link between Ozempic and Wegovy use and a unique form of vision loss, The Yost Legal Group has made the careful decision to take cases for individuals who were prescribed Ozempic or Wegovy and then suffered vision loss as a result of taking those medications.

At The Yost Legal Group, we believe people deserve full transparency about the medications they are prescribed by their doctors. Far too many individuals were never warned about a potentially blinding condition called non-arteritic anterior ischemic optic neuropathy (NAION).

Patients were told about the benefits of blood sugar control or weight loss, but not about the devastating impact on their eyesight. It is not their fault. They trusted their doctors and the billion-dollar corporation that manufactured and marketed these drugs, which sold the promise of a healthier life. But users were misled.

If you or a loved one were prescribed Ozempic or Wegovy and experienced sudden vision loss or blindness, you might have NAION. Seek a diagnosis from a medical professional. 

If you or a loved one has been diagnosed with NAION after using Ozempic or Wegovy, you deserve to know your rights. Call the trusted defective drug lawyers at The Yost Legal Group today for a free consultation: 1-800-967-8529.

Adverse Vision Changes After Ozempic and Wegovy Usage

Understanding the Risk: What Is NAION?

NAION stands for non-arteritic anterior ischemic optic neuropathy. That is a mouthful (we know), so let us put it into layman’s terms: the front part of the optic nerve in your eye loses its blood supply. When that happens, nerve fibers die, and vision goes dark. The condition works quickly, painlessly, and often in just one eye.

Recovery is often incomplete, and for many people, the vision they lose does not come back. Over time, without proper warning or monitoring, it can lead to permanent blindness.

This is not a mild “blur” side effect. This is a severe, life-altering event. Optic nerve blood flow is compromised, and once damage sets in, there is no guaranteed fix.

Who Is at Risk for Developing NAION

Why Are Semaglutides Like Ozempic and Wegovy Under Fire?

Ozempic and Wegovy both rely on the same active ingredient: semaglutide, a GLP-1 receptor agonist. These drugs revolutionized treatment for type 2 diabetes and obesity, but their popularity skyrocketed almost overnight once they were linked to weight loss.

However, not all side effects were positive, and more troubling signs emerged as more people used them for more extended periods.

Scientists in a JAMA Ophthalmology study published in February 2025 reviewed data from over 16,000 patients with type 2 diabetes and found that those on semaglutide had a 32% higher risk of developing NAION compared to those who were not taking the drug.

Semaglutides are also known to change blood sugar levels dramatically, which makes sense as they are diabetes medications. These swings, however, can shift the shape of the eyes’ lenses, which may contribute to blurred vision, retinal stress, or other complications.

For diabetic patients, rapidly dropping blood sugar can paradoxically worsen preexisting diabetic retinopathy. In some people, retinal damage from years of high blood sugar can worsen as glucose levels normalize.

These are not hypothetical risks. They are real, documented, and potentially devastating to vision.

Why Novo Nordisk Failed to Warn Patients of the Risk of NAION and Permanent Blindness

How People Were Misled. And Why That Matters

When millions are prescribed a medication, there is a responsibility to clearly spell out risks. That did not always happen here.

·     No Adequate Warning of Permanent Vision Loss: The current drug labels mention vision changes, but very few mention NAION. That is not a simple oversight. In our legally informed opinion, that is a legal and ethical failure.

·     Big Pharma Profits vs. Patient Safety: Novo Nordisk, the maker of Ozempic and Wegovy, made billions selling these drugs. But how aggressively did they communicate the full range of risks? Based upon what we are seeing, the answer is “Not nearly enough.” Patients trusted their doctors. Doctors trusted the studies. And patients took the drugs home, never the wiser that, in very rare cases, they were signing on for a potential fight to keep their sight.

·     Lawsuits Are Not About Blame. They Are About Accountability: We are not here to shame patients. We are not suing doctors, many of whom were misled themselves. This was never about “You should have known better.” This is about what a billion-dollar Big Pharma company knew about its drug and what it did not disclose to potential users. This is about what patients were never told. This is about the drug maker’s failure to warn its users about a devastating potential adverse side effect. Whether it is a failure to warn claim or a broader product liability case for a defective drug, people who lost their vision deserve their chance at justice.

Who Is at Risk for Developing NAION?

NAION is not random. There are risk factors that seem to make some people more vulnerable. Those at an increased risk are people with the following conditions:

Diabetes
High blood pressure
High cholesterol
Sleep apnea
Crowded optic nerve head

Are living with any of these conditions? Please consult a medical professional before starting semaglutide. If you are living with any of these conditions and have suffered vision loss after using Ozempic or Wegovy, seek medical attention immediately.

Has you or a loved one lost their vision after using Ozempic for weight loss or Wegovy? You may qualify to file an Ozempic lawsuit. Call the experienced product liability lawyers at The Yost Legal Group today at 1-800-967-8529.

Ophthalmologists and Neuro-Ophthalmologists Raise Concerns

Some doctors call the link between semaglutide and non-arthritic anterior ischemic optic neuropathy (NAION) “plausible but not yet proven,” which underscores how urgently we need more data. Others point out that even temporary side effects, such as blurry vision (especially in older people), need to be closely monitored.

As one retina specialist explained, blood sugar control can change the shape of the lens, which can blur vision, but the worst risk is to the optic nerve.

Experts recommend a baseline eye exam before starting semaglutide, followed by ongoing ophthalmologic monitoring during treatment, particularly for patients with eye risk factors or prior diabetic eye disease.

What Ozempic and Wegovy Maker Can Do

When lawsuits are filed, they do more than seek justice for affected individuals. These cases can force a change that protects potential patients in the future. Common industry-wide outcomes from mass tort lawsuits against defective drug manufacturers include:

Better Labeling: We can demand that their medication guides include a clear, bold warning about the risk of NAION and permanent vision loss.

Stronger Monitoring Protocols: Suits can push for mandatory eye exams and closer follow-up for people starting semaglutide.

Reinforced Accountability: When pharmaceutical companies are held to account, it sends a message: prioritizing profits over people’s health is not acceptable.

Adverse Vision Changes After Ozempic/Wegovy? What to Do Now

1.       Seek Medical Evaluation Immediately:

If you have noticed vision changes (even slight blurriness or a haze), reach out to an eye doctor. Mention that you have used semaglutide (Ozempic or Wegovy). Ask about the risk of NAION and whether you should be monitored more closely.

2.       Document Everything:

Keep notes of when you started the medication, what dose you used, when vision symptoms began, and all your medical records (eye exams, ophthalmologists’ notes, and any vision-related tests).

3.       Talk to a Lawyer Who Understands These Cases:

Our experienced product liability law firm handles a wide range of product liability cases. We know how to review your medical timeline, connect the dots, and hold large companies accountable. Ozempic blindness claims and GLP-1 drugs vision loss claims are being reviewed by our legal team.

You took a medication to improve your life, to manage your diabetes or weight and you followed the instructions. You trusted your healthcare providers and the drug manufacturer. But you were not told about the potential risks and side effects, including severe eye conditions.

How The Yost Legal Group Can Help

When drug manufacturers fail to warn people of serious, permanent risks, they put profit over people. They fail in their responsibility to the very individuals who helped them profit.

At The Yost Legal Group, we refuse to let that stand. We will press for accountability. We will demand transparency. And we will fight to make sure no one else has to face the darkness alone.

If you or someone you know was prescribed Ozempic or Wegovy and then suffered sudden vision loss or blindness, contact The Yost Legal Group. Do not wait. There is no time to delay when your vision is at stake. Call 1-800-967-8529 for a free case consultation with a compassionate defective drug attorney.

Semaglutide Lawsuit – Ozempic Lawyer – Wegovy Lawyer

Wegovy Lawsuit – Blindness From Ozempic – Weight Loss Medications

The Legal Basis for the Wegovy & Ozempic NAION Lawsuits

Posted on by Loni Liss

Novo Nordisk (Novo) is currently embroiled in a highly publicized and significant legal battle regarding the adequacy of its warning labels for its medications, Ozempic and Wegovy.

Over 1,500 product liability lawsuits against Novo Nordisk allege that the company failed to sufficiently warn of the potentially dangerous risks associated with Ozempic and Wegovy—specifically, vision loss or blindness from Non-arteritic anterior ischemic optic neuropathy (NAION).

This litigation is likely to gain momentum over time. It could become one of the costliest litigations in the history of product liability and pharmaceutical litigation.

What are NAION Non-arteritic anterior ischemic optic neuropathy Symptoms

About Ozempic and Wegovy

Ozempic and Wegovy are incretin mimetic medications that contain the active ingredient semaglutide. Incretin mimetics stimulate the pancreas to increase the production of insulin by imitating the incretin hormone that is naturally produced in the human body, glucagon-like peptide-1 (GLP-1).

Thus, they are part of a class of drugs called GLP-1. The increase in insulin lowers glucose levels in patients with type 2 diabetes, effectively controlling their metabolic condition.

The use of incretin mimetics has also been found to suppress appetite by increasing feelings of satiety, resulting in weight loss among its users.

Ozempic and Wegovy are once-weekly injectable medications approved by the United States Food and Drug Administration (FDA) in December 2017 to lower blood glucose levels in adults with type 2 diabetes and to aid in weight loss, respectively.

A licensed medical clinician must prescribe them to ensure that the patient receives the correct therapeutic dose.

After receiving the proper dose, the medication can be self-administered. Along with a balanced diet and regular exercise, Ozempic and Wegovy are intended for long-term use.

Non-arteritic anterior ischemic optic neuropathy (NAION caused by Ozempic and Wegovy

Novo Failed to Warn Patients of Risk of Vision Loss and Blindness

A “failure to warn” product liability lawsuit is based on the premise that a manufacturer or other company in the chain of distribution knew that its product could be harmful to consumers and failed to provide timely or adequate warnings to the public of these potential risks, causing harm to consumers.

In a failure to warn lawsuit based on strict liability, Plaintiffs must allege the following:

  1. The manufacturer knew of the danger posed by the product
  2. The manufacturer had a duty to warn its consumers of this product-related danger
  3. The manufacturer failed to warn
  4. The manufacturer’s failure to warn caused the plaintiff’s injury

What is NAION?

Non-arteritic anterior ischemic optic neuropathy (NAION) is a rare condition of the eye that can cause irreversible vision loss or complete blindness due to injury to the optic nerve.

NAION is a medical condition where there is a sudden loss of blood flow to the optic nerve, which connects your eyes to your brain. This lack of blood flow can damage the optic nerve, resulting in sudden vision loss, typically in one eye.

NAION is not caused by inflammation or blocked arteries (that’s what “non-arteritic” means), but rather by poor circulation or other risk factors like high blood pressure, diabetes, or sleep apnea.

The vision loss from NAION often happens quickly and can be permanent. There is currently no proven treatment to restore vision once it has been lost due to this condition. That is why it is so vital for people to be aware of any possible risks, especially when taking medications that may increase the chance of developing NAION.

What are NAION Symptoms?

The main symptoms of NAION (Non-arteritic anterior ischemic optic neuropathy) usually include:

–      Sudden, painless vision loss in one eye—often noticed upon waking up

–      Blurry or dim vision, sometimes described as a shadow or dark area in the upper or lower part of the visual field

–      Colors may appear less bright or washed out

–      Some people notice trouble seeing out of the corner of their eye or a loss of side vision

NAION does not usually cause pain or redness in the eye. If you notice any sudden changes in your vision, it’s important to contact an eye doctor right away.

Failure to Warn Patients of NAION Risk.

Novo knew or should have known of the elevated risk of this condition for consumers of its product based on emerging scientific evidence indicating the connection.

Manufacturers have a corporate responsibility and legal duty to provide clear and comprehensive warnings about the risks associated with their products. Then, consumers can make an informed decision with their healthcare provider about whether a medication is best suited for their needs.

Novo failed to fulfill its duty to warn of this risk factor in a timely manner. Based on the failure to warn, the blindness lawsuits allege that the lack of adequate warnings created a lack of informed consent and ultimately caused harm to consumers.

Call The Yost Legal Group to file your Ozempic & Wegovy Blindness Lawsuit.

The Yost Legal Group product liability attorneys are filing Ozempic lawsuits and Wegovy lawsuits. We are pursuing cases of individuals who developed non-arteritic anterior ischemic optic neuropathy (NAION) after using either Ozempic or Wegovy.

Have you been diagnosed with NAION vision loss? Have you experienced partial or total blindness after using Ozempic or Wegovy? (whose active ingredient is also semaglutide), You may be entitled to compensation.

Call experienced attorneys for defective products today at 1 (800) YOST-LAW (1-800-967-8529). You can also fill out the Free Consultation form on our website.

We will contact you shortly to conduct a free case review. And discuss whether you qualify to file an Ozempic Lawsuit or a Wegovy Lawsuit.

Product Liability Lawyers – Novo Nordisk Lawsuit – Defective Product Lawyers

Naion Eye – Semaglutide Lawsuit – Causes of Naion – Naion Treatment

Know Your Rights About Filing a Clonazepam Lawsuit

Posted on by Loni Liss

In November 2024, thousands of patients and families across the United States were shocked to learn about a significant recall involving a widely prescribed anxiety medication: Clonazepam, also known by its brand name, Klonopin. Individuals across the country are filing clonazepam lawsuits.

The recall, announced by Endo, Inc.—the drug manufacturer of the orally disintegrating Clonazepam tablets—was prompted by a dangerous mislabeling issue that put patients at risk of accidental overdose.

If you or a loved one has experienced severe side effects or adverse reactions after taking recalled Clonazepam Orally Disintegrating Tablets, you may be eligible to file a Clonazepam lawsuit and pursue compensation for your injuries.

At The Yost Legal Group, our experienced product liability attorneys are dedicated to holding pharmaceutical companies accountable and ensuring that victims receive the justice and support they deserve.

In this blog, we’ll break down what happened with the Clonazepam recall, the potential dangers, how to file a product liability claim, and how The Yost Legal Group can help.

Know Your Rights About Filing a Clonazepam Lawsuit

What Is Clonazepam (Klonopin)?

Clonazepam is a prescription medication commonly used to treat anxiety disorders, panic attacks, and certain types of seizures.

As a benzodiazepine, Clonazepam works by calming the brain and nerves, making it a trusted option for millions of patients who rely on it for daily symptom management.

Klonopin, the brand name version, is well-known for its efficacy and is often prescribed in both standard and orally disintegrating tablet (ODT) forms.

Details of the 2024 FDA Clonazepam Recall

In November 2024, Endo, Inc. announced a voluntary recall of specific lots of Clonazepam Orally Disintegrating Tablets (ODT) after discovering a serious labeling error.

According to the FDA’s official recall notice, the outer packaging of certain Clonazepam ODT products listed a lower dosage than what was actually contained in the blister packs.

In other words, patients who believed they were taking a lower, doctor-recommended dose may have inadvertently ingested a much higher amount of the drug.

Example of the Mislabeling Issue

Imagine receiving a prescription labeled as 0.5 mg tablets, only to discover the actual blister packs inside contain 2 mg tablets—a fourfold increase in dosage.

For patients with anxiety or seizure disorders, this discrepancy can have life-threatening consequences.

Why Is the Mislabeling of Clonazepam so Dangerous?

Benzodiazepines like Clonazepam are potent medications. Even small increases in dosage can cause:

–             Severe drowsiness or sedation

–             Confusion and impaired coordination

–             Respiratory depression (slow or shallow breathing)

–             Risk of overdose, especially in elderly patients or those with other health conditions

For some, accidental overdose can lead to hospitalization, long-term health complications, or even death.

Who Is Affected by the Clonazepam Recall?

The recall specifically involves certain lots of Clonazepam Orally Disintegrating Tablets manufactured by Endo, Inc.

If you or your loved one filled a prescription for Clonazepam ODT in late 2024, it’s critical to check whether your medication is part of the recall.

How to Check Your Medication:

Visit the FDA’s recall page here for a complete list of affected lot numbers and photos of the recalled packaging.

–             Compare the lot number on your medication’s blister pack to those listed by the FDA.

–             If you find a match, stop taking the medication immediately and contact your healthcare provider for guidance.

Risks and Injuries from Taking a Higher-Than-Recommended Dose of Clonazepam

The mislabeling of Clonazepam Orally Disintegrating Tablets is not just a paperwork error—it’s a potentially life-altering or life-threatening mistake.

When patients unknowingly take a much higher dose of Clonazepam than their doctor intended, the risks go far beyond mild side effects. The consequences can be severe and sometimes catastrophic.

Severe Drowsiness and Sedation

Clonazepam is a powerful sedative, and even at prescribed doses, it can cause drowsiness. But when the dose is accidentally multiplied, the sedative effects can become overwhelming. Patients may experience:

–             Extreme fatigue

–             Inability to stay awake

–             Difficulty responding to their environment

Real-World Impact:

Severe drowsiness and sedation dramatically increase the risk of motor vehicle accidents.

A person who takes a higher dose than intended may feel too tired to drive safely, react slowly to hazards, or even fall asleep at the wheel.

This can result in putting not only the patient but also passengers, other drivers, and pedestrians at risk.

–             Rear-end collisions

–             Running off the road

–             Causing multi-vehicle accidents

Falls, Traumatic Brain Injuries, and Broken Bones from Clonazepam Overdose

The sedative effects of Clonazepam can also lead to loss of balance and falls, especially in older adults or those with existing mobility issues. A sudden, unexplained fall can cause:

–             Traumatic brain injuries (TBI)

–             Concussions

–             Broken hips, wrists, or other bones

–             Internal bleeding

These injuries often require emergency medical care, surgery, and long-term rehabilitation. In some cases, the consequences can be permanent or even fatal.

Confusion and Impaired Coordination

A higher-than-recommended dose of Clonazepam can cause profound confusion, memory problems, and impaired coordination. Patients may become disoriented, unable to follow instructions, or struggle to perform everyday tasks.

Who Is Affected by the Clonazepam Recall

Workplace Dangers from Clozazapan Overdose

For individuals who operate vehicles, heavy equipment, or machinery as part of their job, these symptoms can be especially hazardous. Confusion and poor coordination can lead to:

–             Driving errors, causing serious or fatal crashes

–             Mishandling of industrial equipment, resulting in workplace accidents

–             Dropping heavy objects or tools, risking injury to themselves or coworkers

–             Respiratory Depression and Life-Threatening Overdose

In the most severe cases, taking too much Clonazepam can slow breathing to dangerously low levels—a condition known as respiratory depression. Without prompt medical intervention, this can lead to loss of consciousness, brain damage, or death.

Steps to Take if You Took The Mislabeled Clonazepam

Seek Medical Attention: If you are experiencing symptoms of overdose or any unusual side effects, seek medical help immediately.

Preserve Your Medication: Do not throw away the recalled tablets or packaging. These can serve as critical evidence in a potential lawsuit.

Document Everything: Keep a record of your symptoms, medical visits, and any correspondence with your pharmacy or healthcare provider regarding the recall.

Contact a Product Liability Attorney: Legal professionals can help you understand your rights and the next steps for pursuing compensation.

Legal Rights: Can You File a Clonazepam Lawsuit?

Pharmaceutical companies have a legal duty to ensure their products are safe and accurately labeled.

When a company fails to meet this obligation, and patients are harmed as a result, victims have the right to seek justice through a product liability lawsuit.

You may have a valid Clonazepam Overdose claim if:

–             You or a loved one took the recalled Clonazepam ODT and experienced adverse effects

–             The medication you received was part of the recalled lots

–             You suffered physical, emotional, or financial harm as a result

–             Potential compensation in these cases can cover:

–             Medical expenses (hospitalization, doctor visits, medications)

–             Lost wages due to missed work

–             Pain and suffering

–             Long-term health impacts

–             Wrongful death (in tragic cases involving fatal overdoses)

How The Yost Legal Group Can Help

At The Yost Legal Group, our mission is to advocate for individuals and families harmed by dangerous or defective medications. We understand the fear and frustration that come with medication recalls and unexpected health crises.

Our experienced attorneys for defective products have successfully represented clients in complex pharmaceutical litigation nationwide.

What We Offer:

Free, Confidential Consultation: We’ll review your case, answer your questions, and explain your legal options at no cost.

Contingency Fee Representation: You pay nothing unless we win compensation for you.

Compassionate Support: Our team is dedicated to providing personalized, respectful service every step of the way.

If you believe you have a Clonazepam lawsuit, don’t wait. Evidence can disappear, and strict legal deadlines may apply.

Contact our Defective Drug Lawyers Today

If the Clonazepam recall has negatively impacted you or a loved one, you deserve answers, accountability, and compensation for your suffering. The Yost Legal Group is here to help.

Contact our product liability lawyers today to schedule your free consultation:

Phone: (800)-YOST-LAW or (866)-841-4597

Text: 1-410-659-6800

Website: www.yostlaw.com

Let us help you protect your rights and pursue the justice you deserve.

Resources:

FDA Recall Notice: Endo Expands Voluntary Recall of Clonazepam Orally Disintegrating Tablets

Final Thoughts

Medication errors can have devastating consequences, but you are not alone. With an experienced pharmaceutical liability lawyer, you can hold negligent manufacturers accountable.

This will help secure a safer future for yourself and your loved ones. If you have questions or need help navigating your next steps, The Yost Legal Group is just a call or text away. Please continue to check our website for Clonazepam overdose updates.

Clonazepam Lawyer – Product Injury Attorney – Drug Recall Lawyers

Clonazepam Recall Law Firm – Clonazepam Injuries – Defective Product Lawyers

FDA Announces Voluntary Clonazepam Recall

Posted on by Loni Liss

The Benzodiazepine, a Generic Form of Klonopin, Had a “Life-Threatening” Labeling Error

A vital safety alert was issued for Clonazepam users. Endo, Inc., a pharmaceutical company based in Pennsylvania, has recalled its seizure medication, Clonazepam tablets.

The recall is due to a mistake in labeling the product strength on the carton. Such a serious error could lead to life-threatening consequences for thousands of users.

The recall is part of an FDA investigation. Endo, Inc. expanded its initial voluntary recall from July 16. The FDA announced the expanded recall in an alert on Nov. 19.

Clonazepam pillss recalled from the market

Urgent Warning for Clonazepam Users—Verify Your Dose Now

If you use clonazepam benzodiazepine, check your product’s labeling immediately. People who take a higher dose of Clonazepam could face serious health risks, including:

–      Extreme drowsiness

–      Confusion

–      Dizziness

–      Slowed reflexes

–      Lack of coordination

–      Low muscle tone

–      Life-threatening respiratory depression

There is a significant chance of life-threatening respiratory depression:

  • Particularly for individuals with lung conditions
  • Those already prescribed high doses of Clonazepam
  • Patients taking other medications that suppress breathing

If you have experienced a severe adverse reaction from Clonazepam, contact 1-800-967-8529 for a 100% Free and Confidential consultation. The Yost Legal Group is a highly experienced Product Liability law firm. Our Clonazepam lawyers will investigate what happened and fight to seek the justice and financial compensation you deserve.

 Clonazepam can cause adverse reactions

What Is Clonazepam?

The drug Clonazepam is a generic drug under the benzodiazepine class of depressant drugs.

Depressants: These types of drugs affect the brain’s activity. They slow neurotransmission levels and decrease electrical activity in the brain. Depressants also inhibit an individual’s ability to feel arousal and stimulation.

This reduction in brain activity is why depressant drugs can be effective when used correctly. A medical professional prescribes them to relieve disorders and symptoms such as:

  • Anxiety disorders
  • Depression
  • Insomnia
  • Obsessive-compulsive disorder
  • Seizures

Alcohol, benzodiazepines, and cannabis are some of the most common types of depressant drugs.

Benzodiazepines: Benzodiazepines, known as “benzos,” are a class of depressant drugs. This type of drug derives its name from its chemical compound, which is a fusion of benzene and diazepine rings.

Medically, benzodiazepines are most often used to treat anxiety and panic disorders, insomnia, and seizures. Common types of benzodiazepines include alprazolam (Xanax®), clonazepam (Klonopin®), and diazepam (Valium®).

Clonazepam is a generic benzodiazepine sold under the brand name Klonopin®, which more people are probably familiar with. This recall, however, pertains only to the generic version.

Clonazepam side effects, file a Clonazepam lawsuit

Severe Health Risks Linked to Incorrect Clonazepam Dosage

Clonazepam is often used to treat anxiety disorders, bipolar mania, and seizures. Anyone with these ailments and conditions needs regular help. For some people, it might be difficult to make it through a day without their prescribed medication.

Pharmaceutical companies have a clear duty to ensure their products are safe. This includes items people apply, ingest, or inject. They must also make sure their product labels are accurate. These labels tell people how to use their medications safely.

The recall for Clonazepam relates to the tablet version, as the drug is most often taken orally.

The packaging had a labeling mistake. The company said it was “possibly life-threatening.” This was also noted in the FDA safety warning. If a user took the wrong amount of the medication, it could be dangerous. This happened because the number of milligrams in each tablet was incorrect.

If you or someone you know may have been affected, seek medical attention immediately. Contact The Yost Legal Group’s “Dangerous Drugs” division to learn about your legal rights.

Life-Threatening Clonazepam Risks—Know Your Legal Rights

This was no small mistake. In 1960, Clonazepam was patented and became available in the United States in 1975. Doctors have prescribed the drug often since it has been on the market for decades.

According to ClinCalc.com, Clonazepam was the 57th most prescribed drug in the United States in 2022. More than 11.5 million prescriptions of Clonazepam were made out to nearly 2 million patients in 2022.

This mislabeling put millions of people at risk. Furthermore, it was not the first time Endo was derelict in its duties regarding labeling its clonazepam packaging.

The product recall focuses on Clonazepam drug side effects, one of which can result in death from Clonazepam. The product liability lawyers at The Yost Legal Group are here to help. Many FDA recalls exist; the highest level occurs when the FDA issues an FDA Black Boxed Warning. This usually happens when a company is about to remove a drug from the market.

The First Clonazepam Recall of 2024

On July 17, 2024, the FDA published a safety alert that it voluntarily recalled many orally disintegrating drugs due to mislabeling.

Endo announced that the lot it was recalling included packaging that under-reported the strength of each tablet:

“The product lot [550147301] is being recalled due to mislabeling where an incorrect strength appears on the cartons of some packs to show the product strength as 0.125 mg and not 0.25 mg due to an error at a third-party packager.”

Regardless of the mistake by the “third-party packager,” Endo bears responsibility as the drug manufacturer and the employer of the company that packages its medication.

However, it was just one lot and one recall. As Endo noted in its statement, “to date [the company] has not received any reports of adverse events associated with this product lot recall.”

But it would not remain just one lot and one recall for much longer.

If a defective drug harmed you or a loved one, you may have a case and be entitled to compensation. Call or text the experienced defective drug lawyers at The Yost Legal Group today for a free consultation: 410-659-6800.

The Second Clonazepam Recall of 2024

As previously stated, Endo voluntarily recalled Clonazepam in November 2024, and the FDA ran a safety alert. The second recall, however, was not just to announce the recall of a second lot. The alert included a whopping 16 lots of the drug.

The table below includes the product description (Clonazepam Orally Disintegrating Tablets), the National Drug Code number, and the lot number.

Potential Product Description / NDC Number  Lot Number Expiry Date

Clonazepam ODT, USP (C-IV) 2mg / 49884-310-02 550176501 Feb 2027

550176601 Feb 2027

Clonazepam ODT, USP (C-IV) 0.125mg / 49884-306-02 550174101 Jan 2027

Clonazepam ODT, USP (C-IV) 0.25mg / 49884-307-02 550142801 Aug 2026

550142901 Aug 2026

550143001 Aug 2026

550143101 Aug 2026

550143201 Aug 2026

550143301 Aug 2026

550143401 Aug 2026

550147201 Aug 2026

550147401 Aug 2026

Clonazepam ODT, USP (C-IV) 1mg / 49884-309-02 550145201 Aug 2026

550175901 Feb 2027

550176001 Feb 2027

550176201 Feb 2027

Again, Endo placed the blame on its third-party packager:

“Endo’s ongoing investigation has identified the possibility that the Clonazepam product lots listed below contain a limited number of cartons printed with the incorrect strength and National Drug Code (NDC) code due to an error by a third-party packager.”

Serious Side Effects from Clonazepam? We Can Help

Endo is responsible for its medication, and for the third-party packager/s, it hires to label its products. Although the actual medication is not defective, it is still vital to ensure the labeling is correct so that people using the drug can do so safely.

This repeat of negligence with mislabeling puts real people at risk. As of 2022, nearly 2 million people were prescribed Clonazepam, and now there are 16 recalled lots. Endo put its customers in harm’s way.

We do not know how the packages got the wrong information. However, we have seen how small details can be missed at big pharmaceutical companies. Some companies cut corners to save money, which harms people. The result is almost always putting innocent people at risk.

Clonazepam Adverse Reaction? Seek Justice Today

The Yost Legal Group has a long history of representing individuals and their families after a defective drug altered someone’s life.

Drug companies are billion-dollar multinational corporations with some of the best pharmaceutical lawyers in the world. A skilled and experienced defective drug lawyer must handle the complex legal issues when suing a Big Pharma company.

That is where The Yost Legal Group’s accomplished defective drug lawyers factor into the equation. As leading personal injury attorneys, we file product liability lawsuits every day. Let us file your Clonazepam claim.

Many cases involve prescription drugs because of “failure to warn” and “serious pharmaceutical side effects.”

If a defective drug has harmed you or a loved one, please get in touch with The Yost Legal Group today. Our defective drug lawyers will start working on your case right away. They will help you understand your rights to seek the compensation and justice you deserve. Call or text us at 410-659-6800.

All consultations are free, and you do not owe us anything unless we take on and win your case.

Defective Products Lawyers – Defective Products Law Firm – Products Liability Attorneys

Products Liability Attorney Recall – Clonazepam Warnings –

Depo Provera Lawsuit

Posted on by Loni Liss

A new study raises concerns about the potential link between Depo-Provera® contraceptive injections and meningioma brain tumors. Research suggests women who have used Depo-Provera® long-term may face an increased risk of developing this condition. Do you qualify to file a Depo Provera lawsuit?

If you or someone you love has been diagnosed with a meningioma after using Depo-Provera®, you may qualify to file a Depo Provera lawsuit. Let us help you seek the justice and financial compensation you deserve.

Contact The Yost Legal Group today at 800-967-8529 for a free consultation. Our experienced Depo attorneys are ready to help you explore your legal options. Don’t wait—call now.

brain mass meningioma side effects from depo birth control shot

Know Your Rights After Depo-Provera Meningiomas Diagnosis

  • Prolonged Use of Depo-Provera® May Increase Risk of Brain Tumors
  • Recent research highlights an important concern for women using Depo-Provera® as a contraceptive. Studies have shown that extended use of Depo-Provera® significantly increases the risk of developing meningioma, a type of brain tumor.
  • 5.6x Higher Risk with Depo-Provera Women who use Depo-Provera® for more than one year face a 5.6-times higher risk of developing meningiomas, according to a study in the British Medical Journal. If you’ve experienced health complications linked to Depo-Provera®, seek guidance today.
  • Meningiomas May Require Surgical Treatment – Meningiomas are tumors that can grow and put dangerous pressure on the brain. These growths often demand invasive surgery, which comes with serious health risks and potential complications. If you or a loved one are facing a diagnosis, consult a healthcare specialist immediately for guidance and treatment options. Early intervention is critical.
  • Common Symptoms of Meningioma: Persistent headaches, vision issues, seizures, hearing loss, or weakness in the limbs could be symptoms of a meningioma—a type of brain tumor. These signs should not be ignored. If you’re experiencing any of these symptoms, consult a healthcare professional immediately for evaluation. Early detection can make all the difference.
  • Protect Your Right to Compensation: If you’ve developed a meningioma after using Depo-Provera®, you could be eligible for compensation. This may cover medical expenses, lost wages, pain and suffering and more.
  • Act Quickly to Protect Your Rights – Statutes of limitations impose strict deadlines. Delaying action could jeopardize your legal claim.
  • Get a Free Consultation Today – Contact us now to confidentially discuss your case and explore your legal options with our experienced team.

depo provera lawsuit, depo shot side effects

Possible 5.6x higher risk of meningioma with Depo-Provera® use.

Recent Study Links Depo-Provera® to Meningioma

Depo-Provera® is a hormonal birth control method delivered via injection every three months. It contains medroxyprogesterone acetate, a synthetic form of progesterone, and works by preventing ovulation and changing the uterine lining to reduce the chances of pregnancy.

depo provera birth control shot side effects

Key Information About Depo-Provera® You Need to Know

  • Purpose: Depo-Provera® is a trusted, long-lasting contraceptive designed to prevent pregnancy effectively.
  • Administration: It’s administered through an intramuscular injection in the arm or buttock every 12 weeks, ensuring consistent protection.
  • Effectiveness: When used as directed, it is over 99% effective in preventing pregnancy, offering reliable peace of mind.
  • Popularity: This method is favored by millions of women globally for its convenience and highly dependable results.

A recent study published in the British Medical Journal in March 2024 revealed concerning findings about Depo-Provera®, a widely trusted contraceptive.

The study indicates a potential link between prolonged use of Depo-Provera® and an increased risk of brain tumors, specifically meningiomas.

Women who have used Depo-Provera for over a year may face a significantly higher risk of developing these tumors. If you or a loved one has been diagnosed with a brain tumor after using Depo-Provera®, it is crucial to act now.

Contact The Yost Legal Group to learn more about the Depo Provera litigation. Contact us for a FREE, no-obligation consultation today.

The experienced defective products attorneys at The Yost Legal Group are here to support you. We are helping women across the U.S. file dangerous drug lawsuits and seek justice. Call us today at [Phone Number] for a free consultation. Don’t wait—your health and rights matter.

Key Findings on Depo-Provera® and Meningioma Risk

A new study reveals significant findings about the connection between Depo-Provera® and intracranial meningiomas. Here’s what you need to know:

  • Higher Risk Identified: Women who used Depo-Provera® for over a year faced a 5.6x increased risk of developing intracranial meningiomas compared to women who did not use it.
  • Reliable Data: The analysis was conducted on medical records from over 100,000 women through the French National Health Data System.
  • Long-Term Use Concerns: Risks were significantly higher among women who used Depo-Provera® for extended periods, pointing to potential dangers with prolonged use.
  • Specific to Depo-Provera®: Other progestogens, such as progesterone or levonorgestrel intrauterine systems, did not show an increased risk, underlining a unique concern with Depo-Provera®.

Key Implications of the Depo Side Effects Findings

  • Substantial Risk Increase: The study reveals a 5.6-fold increase in the risk of meningioma linked to the use of Depo-Provera®, underscoring a significant and alarming association.
  • Prolonged Use is Riskier: Long-term users face an escalated risk, highlighting the critical role duration plays in user vulnerability.
  • Insufficient Awareness: Many women may have been exposed to this elevated risk without proper disclosure or warnings.
  • Call for Immediate Regulatory Action: These findings signal an urgent need for regulatory agencies to reassess the safety of Depo-Provera®, implement additional warnings, and evaluate potential restrictions.

Your Legal Rights After a Meningioma Diagnosis

Pharmaceutical companies must prioritize the safety of their products and fully inform consumers about any potential risks associated with their drugs.

If you’ve been diagnosed with a meningioma after using Depo-Provera®, understanding Pfizer Inc.’s responsibilities as the drug’s manufacturer is key.

Failures to identify and disclose the risk of meningiomas early in Depo-Provera’s market lifecycle may have caused significant harm to consumers. It’s critical to know your legal rights and take action now.

Filing a Depo Provera lawsuit is the first step toward seeking justice. Contact The Yost Legal Group at 1-410-659-6800 for a free consultation.

Our experienced Depo Provera lawyers are here to provide guidance, support, and fight for justice on your behalf. Don’t wait—your path to justice could begin today.

Potential Failure to Properly Test the Product

  • Insufficient Research: There may have been a lack of thorough studies to assess long-term neurological effects.
  • Ignored Warnings: Early reports of adverse effects might have been overlooked, raising concerns about due diligence.

Possible Failure to Provide Adequate Warnings

  • Misleading Representations: Marketing efforts could prioritize benefits while downplaying serious risks, potentially putting consumers at risk.

Market Effects of Depo-Provera®

  • Failure to Report Adverse Events: Evidence suggests a possible delay in the timely reporting of meningioma cases linked to the use of Depo-Provera®.
  • Insufficient Action on Emerging Evidence: Reports point to a lack of prompt updates to warnings or further research being conducted to address the newly identified risks.

The Yost Legal Group Will Protect Your Rights

If you or a loved one have experienced adverse effects, you may have a claim against the drug manufacturer. Contact The Yost Legal Group at 1-410-659-6800 for a free consultation. Our trusted team is here to provide guidance and advocate for your rights. We will file a Depo Provera lawsuit on your behalf.

Free case evaluations are now available for women who developed meningioma after using Depo-Provera®. Contact us today to explore your legal options and seek the justice you deserve.

New York Times Finally Covers Hair Relaxer Litigation

Posted on by Loni Liss

After 8,000 Hair Relaxer Lawsuits Filed, Mainstream Media Pay Attention to Cancer Risk

The Hidden Dangers of Hair Relaxers for Black Women Exposed

Earlier this month, on June 13, 2024, New York Times Magazine contributing writer Linda Villarosa published “The Disturbing Truth About Hair Relaxers.” Her expansive 6,300-word article was the ripe fruit born from over a year of research about hair relaxer lawsuits.

She interviewed dozens of scientists, government officials, legal experts, and, most importantly, hair relaxer users. Her findings, while shocking to some, were no surprise to us here at The Yost Legal Group.

We have been covering the hair relaxer litigation for two years. Unfortunately, we are all too familiar with the dangers, cancers, and deaths caused by chemical hair straighteners.

The sub-head continues: “They’ve been linked to reproductive disorders and cancers. Why are they still being marketed so aggressively to Black women?”

The easy answer is “Money.” Cosmetics companies like Avlon, L’Oréal, and Revlon have made hundreds of billions of dollars on the heads of Black women without any regard for the effects upon people’s lives.

Higher Uterine Cancer Risk Linked to Hair Straightening Chemicals, NIH Study Reveals

Hair Straighteners Linked to Uterine Cancer in Black Women

Women who used hair straighteners (mostly Black) were 2.5 times more likely to develop uterine cancer. Black women are more than twice as likely to die from uterine cancer than other racial and ethnic groups studied in 2022 by The Journal of the American Medical Association Oncology.

All peer-reviewed studies we have seen show that chemical hair relaxers and straighteners are carcinogenic, yet cosmetics companies continue to market and sell them. It is time to hold them accountable.

Have you been diagnosed with endometrial cancer (not to be confused with endometriosis), non-serous ovarian cancer, or uterine cancer? Have you used chemical hair relaxers or chemical hair straighteners regularly for years? Contact The Yost Legal Group today at 410-659-6800.

Our lawyers for personal injury will help you understand your rights to file a hair relaxer lawsuit. If you used a dark and lovely relaxer and were diagnosed with any of these cancers, we can file a dark and lovely lawsuit on your behalf.

There is a direct connection between hair relaxers and cancer. Click here for hair relaxer lawsuit update information.

Urgent Warning for Black Women Using Hair Straighteners

If you have never used chemical hair relaxers or lived with someone who did, it might be easy to underestimate how prevalent they are among Black women.

According to a 2019 study published by the Journal of Exposure Science & Environmental Epidemiology (and cited in Villarosa’s New York Times Magazine article), 89% of Black women studied reported having used chemical hair relaxers/straighteners at least once.

In 2011, the United States hair-relaxer market generated $71 million just from sales to salons and other professionals. That revenue dropped to $30 million by 2021. However, those figures do not account for the many products sold off-the-shelf directly to consumers.

If you have been diagnosed with uterine cancer and have used hair relaxers regularly, you should consider filing a product liability lawsuit. The toxic chemicals in chemical hair straightening products increase your risk of cancer.

Although the harmful chemicals in these products were known to be carcinogenic, manufacturers continued to use them in their hair products. Multiple studies show the risk of developing uterine cancer with prolonged use of hair straighteners or relaxer products.

Urgent Warning for Black Women Using Hair Straighteners

Hold Cosmetics Companies Accountable for Carcinogenic Hair Products

Hair Relaxer Brands Linked to Reproductive-Organ Cancers:

·     African Pride

·     Avlon

·     Bantu

·     Carson

·     Dark and Lovely

·     Just for Me

·     L’Oréal

·     ORS Olive Oil

·     Revlon

·     Strength of Nature

Hair-straightening products have been on the market since the 1950s. In many families, brand loyalty has become a tradition. Mothers passed their products onto their daughters, who would eventually pass the products onto their own daughters, and so on and so forth.

Some women have decades of chemical hair relaxer use. The blatant disregard for the health and well-being of women of color by these manufacturers is evident. Now, a light is shining on the truth.

Higher Uterine Cancer Risk Linked to Hair Straightening Chemicals, NIH Study Reveals

A recent study from the National Institutes of Health (NIH) has found that women who use chemical hair straightening products face a higher risk of developing uterine cancer than those who do not use these products.

The research, which drew data from 33,497 U.S. women aged 35-74 participating in the Sister Study, highlighted an increased risk, particularly among Black women, who reportedly use these products more frequently.

According to the findings, women who used hair straighteners more than four times in the previous year were more than twice as likely to develop uterine cancer compared to those who did not use the products.

Notably, the study did not find any associations between uterine cancer and other hair products such as dyes, bleach, highlights, or perms.

Key Findings from the Study:

  • Women who never used hair straighteners had a 1.64% chance of developing uterine cancer by age 70.
  • Frequent users (more than four times a year) faced a risk that increased to 4.05%.
  • During nearly 11 years of follow-up, 378 uterine cancer cases were diagnosed among the participants.

Dr. Alexandra White, head of the NIEHS Environment and Cancer Epidemiology group and the study’s lead author, emphasized the significance of these findings. “This doubling rate is concerning. However, it is important to put this information into context—uterine cancer is a relatively rare type of cancer.”

Despite accounting for about 3% of all new cancer cases, uterine cancer remains the most common cancer of the female reproductive system, with an estimated 65,950 new cases in 2022.

Alarmingly, studies indicate that the incidence rates of uterine cancer have been rising in the United States, especially among Black women.

This study underscores the importance of further research and awareness about the potential risks associated with chemical hair straightening products, particularly within communities that use these products more frequently.

Holding Cosmetics Companies Accountable for Product Safety

As the awareness of the potential risks associated with chemical hair relaxers continues to grow, it is crucial for individuals, especially Black women, to educate themselves about the products they use.

Seeking alternative hair straightening methods that do not contain harmful chemicals can help reduce the risk of developing serious health issues. Additionally, holding cosmetics companies accountable for the safety of their products is essential in ensuring the well-being of consumers.

By staying informed and advocating for safer hair care options, individuals can protect themselves and their loved ones from the dangers linked to chemical hair relaxers.

This prevalence over many decades greatly explains the 8,000+ cases that people have filed so far. In the Hair Relaxers Marketing, Sales Practices, and Products Liability Litigation (MDL-3060) in the United States Judicial Panel of Multidistrict Litigation docket.

The Hidden Dangers of Hair Relaxers for Black Women Exposed

It is nice to see a mainstream media organization like The New York Times finally give this cause the attention it deserves. Hair products that cause cancer should be removed from the market.

Black women have been suffering from preventable endometrial, non-serous ovarian, and uterine cancers likely caused by their chemical hair relaxers for far too long without proper recognition.

If you used chemical hair relaxers or chemical hair straighteners regularly and were diagnosed with endometrial cancer (not to be confused with endometriosis), non-serous ovarian cancer, or uterine cancer, call The Yost Legal Group.

We will file a hair relaxer lawsuit to seek financial compensation for you and your family. Our attorneys for personal injury will fight to seek a hair relaxer settlement.

Our experienced hair relaxer lawyers will work to help you get the justice you deserve. Call or text us at 410-659-6800 for a free consultation.

The Link Between Hair Relaxers and Uterine Cancer

Posted on by Loni Liss

Have you or a loved one been diagnosed with uterine cancer, endometrial cancer, or non-serious ovarian cancer? It may be related to the over-the-counter use of chemical hair relaxers.

The long-term use of these products is linked to an increased risk of certain types of cancers in women. At The Yost Legal Group, we are here to help you navigate this difficult situation and explore your legal options.

Read on to learn more about how hair relaxers could impact your health and what steps you can take.

We will help determine if your use of hair straighteners caused your cancer.

Hair Relaxer Lawsuits filed by The Yost Legal Group, Baltimore, MD

 

The Disturbing Truth About Hair Relaxers and Cancer Risk: What Women Should Know

Chemical hair relaxers have been popular for women looking to straighten their hair for many years. However, recent studies have shown a concerning link between the use of these products and an increased risk of:

– uterine cancer

– endometrial cancer

– non-serous ovarian cancer.

The chemicals in many hair relaxers have been found to disrupt hormone levels in the body, potentially leading to these types of cancers over time.

Have you been using chemical hair relaxers for an extended period and received a cancer diagnosis? Speaking with a Hair Relaxer Attorney at The Yost Legal Group is essential.

Some of these products contain chemicals like:

  • parabens
  • nitrosamines
  • bisphenol A (BPA)
  • metals
  • formaldehyde

These harmful chemicals can cause serious health problems, like certain types of cancer, such as uterine and ovarian cancer.

When you straighten your hair, your scalp absorbs these chemicals instead of them just sitting on your hair. These treatments can be harsh and may cause burns or lesions on your scalp. This can make it easier for harmful substances to enter your body and bloodstream.

One chemical to be particularly mindful of is formaldehyde, a substance notorious for its toxicity and cancer-causing potential. Next time you consider getting your hair straightened, remember that the risks might extend beyond just a bad hair day.

Hair straightener cancer includes uterine cancer, endometrial cancer, or non-serious ovarian cancer.

Stay informed and take care when choosing hair treatments. Your health is worth more than straight hair!

Dark and lovely lawsuit and Olive Oil lawsuit hair relaxers

 

From Straight Hair to Serious Health Concerns: The Cancer Risk of Chemical Relaxers

Our team handles product liability cases and can help you determine if your cancer diagnosis may be related to using these harmful products.

You may be eligible to file a hair relaxer lawsuit against the manufacturers of these hair relaxers and seek compensation for your medical expenses, lost wages, pain and suffering, and other damages.

You can click here to see many of the over-the-counter hair relaxers that are linked to causing cancer. Knowing which hair relaxers cause cancer is an important step. Many women have filed Dark and Lovely lawsuits and Olive Oil hair relaxer lawsuits.

It is crucial for women who have been diagnosed with uterine cancer or related conditions to understand their legal rights and options. You can get the guidance and support you need during this challenging time by contacting The Yost Legal Group.

Our experienced hair relaxer cancer lawyers will review your case thoroughly and work tirelessly to hold responsible parties accountable for any harm caused by their products.

Don’t hesitate to reach out by calling 1-800-967-8529. Your cancer diagnosis may be connected to the use of chemical hair relaxers. If you qualify, we will file a hair relaxer lawsuit.

In addition to seeking legal representation, it is also essential for women who have used chemical hair relaxers in the past to prioritize their health moving forward.

Reconsidering Hair Relaxers: The Alarming Link Between Straighteners and Cancer

Consider switching to natural alternatives or avoiding hair straightening treatments to reduce exposure to potentially harmful chemicals.

Regular check-ups with your healthcare provider can also help catch potential health issues early on.

February 27, 2024, Hair Relaxer Lawsuit Update

At this time, over 8,200 cases are pending in the Multi-District Litigation. Document production and review are extremely important in large litigations such as this.

The Honorable Paul Grimm (retired) was hired as the Special Master for electronic discovery in this litigation.

In this role, he has been assigned to use his legal expertise to review and debrief complex issues and oversee other technical matters as assigned by the Judge.

More African American women have a higher risk of developing uterine cancer from chemical hair straightening products

 

Uterine Cancer and Hair Straighteners

Your health should always come first, especially when faced with a serious diagnosis like uterine cancer. The National Institutes of Health and the National Cancer Institute have warned women of the risks associated with hair straighteners or relaxers.

More African American women have a higher risk of developing uterine cancer from chemical hair straightening products.

If you think chemical hair relaxers caused your cancer, contact The Yost Legal Group for help. We will file a hair relaxer cancer lawsuit on your behalf. Filing a lawsuit will send a strong message to the manufacturers of these dangerous products.

At The Yost Legal Group, our hair relaxer lawyers are dedicated to helping women. Let us work to seek justice and compensation for harm caused by these dangerous products.

Remember that you are not alone in this fight, and we are here to advocate for your rights every step of the way. Filing a hair straightener lawsuit is the first step toward seeking justice.

To learn more, go to https://www.yostlaw.com/hair-relaxing-products-linked-to-uterine-cancer-lawsuits/

The Yost Legal Group is representing women nationwide in filing hair relaxer lawsuits. As a leading personal injury law firm, we handle all types of product liability, birth injury, severe injury, and defective medical device cases.

If you have questions, we will help you find answers.

The Yost Legal Group, personal injury lawyers who fight for justice.

Contact Form

DO I HAVE A CASE?

Contact us at the Yost Legal Group for a free initial consultation. We can help to provide information about ongoing litigation or discuss the circumstances of your individual case. There is no fee or expense unless you recover.